NEW YORK (GenomeWeb) – Eurofins Scientific announced through its subsidiary Viracor-IBT Laboratories that the US Food and Drug Administration has granted emergency use authorization (EUA) for its test for the Zika virus.

The RT-PCR test detects Zika RNA in human serum, plasma, or urine collected from individuals meeting clinical or epidemiological criteria for Zika virus exposure. Missouri-based Viracor-IBT said in a statement that the test does not cross react with other Flaviviruses such as dengue or West Nile, or viruses causing similar symptoms such as chikungunya.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A fire at a Manchester hospital may have destroyed lab equipment and data, the Guardian reports.

Researchers generate a genetic database from skeletal remains from the 1845 Franklin Expedition to the Arctic, Live Science reports.

Researchers in China have begun another trial using CRISPR/Cas9 approaches in cancer patients, according to the Wall Street Journal.

In Science this week: human DNA found in sediments from archeological sites lacking bones, and more.